A global CRO, focused on cardiovascular and central nervous system medicine, selects Clinical Force to improve the Study Startup process and accommodate forecast growth with large studies.
This global organization has grown quickly to 280 staff through new business and a series of strategic mergers and acquisitions. Internal systems for data management and CTMS are being evaluated to determine if they can support future growth and tight time frames when conducting studies. They selected Clinical Force CTMS reduce the time of Study Startup including collection of Regulated Documents and Contract Management during startup.
In addition, they expect to significantly improve the visit report process eliminating current cut and paste tasks with Word processing documents. They also expect to improve the Site payment process by reducing time and cost to pay the sites accurately and timely.
A financial analysis confirmed that they would pay for the system on the first study.